Who we are
Target Malaria project is a not for profit research consortium that is seeking to develop and share new, cost-effective and sustainable novel technology for malaria control in sub-Saharan Africa. Target Malaria started as university-based research programme and has grown to include scientists, stakeholder engagement teams, risk assessment specialists and regulatory experts from Africa, North America and Europe.
Our vision is a world free of malaria
We will develop and share new, cost-effective and sustainable genetic technologies to modify mosquitoes and reduce malaria transmission.
Achieve excellence in all areas of our work, creating a path for responsible research and development of genetic technologies
We will co-develop both our technologies and the associated knowledge base.
Ensure our work is evidence-driven so we can deliver safe and effective technologies.
Be open and accountable in how we work, in our relationships and in our decisions
What is our work?
We are working to reduce the population of the mosquitoes that transmit malaria, and therefore reduce transmission of the malaria parasite
In Uganda, the research is still in its early stage focusing on entomological mosquito collections from Islands within Lake Victoria and mainland field sites located in Mukono and Kayunga districts. At present, our teams are collecting mosquitoes from village sites for purposes of studying mosquito dynamics and behaviour to provide baseline information for the research.
There is ongoing capacity building for staff as well as infrastructural development (construction of a new insectary) at Uganda Virus Research Institute campus in Entebbe.
In Africa, Target Malaria works with partner institutions in Uganda, Mali, Burkina Faso and Ghana. Uganda Virus Research Institute is the partner institution where the Target Malaria project team is based.
Target Malaria receives core funding from the Bill & Melinda Gates Foundation and from the Open Philanthropy Project Fund, an advised fund of Silicon Valley Community Foundation. Specific laboratories also receive additional funding from a variety of sources to support each lab’s work, including the Ministry of Health, Uganda National Council of Science and Technology, Welcome Trust, the European Commission, MRC, NIH and DEFRA.
Imperial College London, CDC Foundation, USA, Fred Hutchinson Cancer Research Centre, USA, , UK, Institut de Recherche en Sciences de la Santé (IRSS), Burkina Faso, Keele University, UK, Malaria Research & Training Center, Université des Sciences, des Techniques et des Technologies de Bamako, Mali, Polo d’Innovazione di Genomica, Genetica e Biologia (Polo GGB), Italy, USA, University of Cambridge, UK, University of Notre Dame, USA, University of Oxford, UK, University of Perugia, Italy, University of Washington, USA.